Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
FMS | Ann: Future Mobility Solutions Limited (“FMS”) – Delisting | 14/10/19 | 0 | 438 | |||
|
|||||||
FMS | Ann: Revised Delisting Timetable | 14/10/19 | 0 | 298 | |||
|
|||||||
FMS | Ann: Future Mobility Solutions Limited (“FMS”) – Delisting | 01/10/19 | 0 | 358 | |||
|
|||||||
FMS | Ann: FMS Delisting Announcement | 01/10/19 | 0 | 325 | |||
|
|||||||
FMS | Ann: Future Mobility Solutions LTD (“FMS”) - Trading Halt Lifted | 30/09/19 | 0 | 304 | |||
|
|||||||
FMS | Ann: FMS Response to Press Speculation | 30/09/19 | 0 | 308 | |||
|
|||||||
FMS | Ann: FMS - Trading Halt of Securities | 27/09/19 | 0 | 688 | |||
|
|||||||
FMS | Ann: Results of Annual Meeting of Shareholders | 27/09/19 | 0 | 318 | |||
|
See All Discussions